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INTRODUCTION 
Osteoporosis is  conditions or changes in bone due to a decrease in bone mass, mineral and 
bone matrix  that  decrease bone density or bone loss. The decrease is  due to imbalance of bone 
resorption to bone formation.  Osteoporosis  process  occurs because of decreased estrogen  in 
post menopausal women. While, osteoblastogenesis in red marrow of myloid tissues (Sabri,  2011; 
Smith 1993) needs estrogen. Osteoblasts are active mature cell function to synthesize organic 
matric and arrange mineralization process (Potu et al. 2009).  
Cissus quadrangularis Linn (Cq) is widely used as alternative treatment of joint pain, venereal 
disease, and osteoporosis in India, Sri Langka and Malaysia (Shirwaikaret al. 2003). In Aceh, Cissus 
quadrangularis Salisb locally known as ekstrak sipatah-patah (ESP) has long been used to treat 
bone fracture. Cq was reported to contain calcium, phosphate, and phytoestrogen having efficacy in 
treating bone fracture, ESPcould be used as an antiosteoporosis. This research was designed to 
study ESP effectivity in improving osteoblastogenesis to inhibitin declining of bone mass on 
ovarectomized rats.  
 
MATERIALS AND METHODS 
Twenty ovarectomizedfemale Sprague Dawley ratsat the age of 50 days were assigned into 5 
groups: Sham rats (OV-0), Ovarectomized rats without ESP administration (OV-1) 
andovarectomizedrats administered ESP at the age of 90 days during 120 days (OV-2), at the age of 
120 days during 90 days (OV-3), at the age 150 days during 60 days (OV-4) with dosage of 750 
mg/kg body weight until the age of 180 days. At the age of 180 days, the experimental rats were 
sacrificed to measure and analyze osteoblast density, bone growth and microstructure.  Paraffin 
sections of tibia fibula stained by using HE method to observe bone microstructure, osteoblast and 
osteoclast density.  
 
RESULTS AND DISCUSSION 
Administration of ESP during 90 days on OV-3 group showed decrease of number of active and 
passive osteoblast with its osteoblast density higher than that of control group (P<0,05). Then, 
active osteoblast density on OV-4 group also showed declining of osteoblasts but similar result  to 
control group (P<0,05). Meanwhile, osteoclast density increased on shorter of administration of 
ESP  duration. Administration of ESP during 120 days on Ovarectomized rat showed lower 
osteoclast density than those of control group and other groups (OV-3 dan OV-4) (P<0,05). 
Administration of ESP on ovarectomized rats at the age of 90 days (OV-3) and 60 days (OV-4) 
showed lower osteoclast density than that of control groups (P<0,05). Administration of ESP  on 
ovarectomized  rats  during  60 days  also showed rare bone marrow and thin trabeculae as well as  
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Table 1. Active and pasive Osteoblast density, osteoclast and  blood vessel in  tibia bone of 
ovarectomized rat administered ESP at the age of 90, 120 and 150 days. 
group 
Osteoblasts 
Osteoclasts Blood vessels 
Aktif Pasif 
OV-0 30,75±19,16c 41,79±17,37b 3,21±2,19c 8,04±3,59b 
OV- 1 28,17±14,79c 38,00±14,52b 16,00±3,32a  8,50±2,60ab 
OV- 2 57,19±18,67a 67,31±18,45a 6,68±3,35b 11,17±5,57a 
OV- 3     38,46±8,36b 45,75±10,45b 7,67±2,59b 10,75±3,37a 
OV- 4 28,39±15,55c 36,39±16,97b 9,06±3,67b 8,71±4,61ab 
 
OV-0 = sham rats; Ovarectomized rats without ESP administration (OV-1), Ovarectomized 
rats with ESP administration during 120 days (OV-2), 90 days (OV-3), and 60 days (OV-4). 
 
 
increased osteoclast density. This condition showed that increase of calcium concentration of bone 
is  influenced by duration of ESP administration during treatment. Phytoestrogen of ESP has role as 
estrogen of bone formation to  decrease bone resorption. On the other side,  estrogen also can 
inhibit parathyroid hormone activity on resorption process through increasing calcitonin (Sabri, 
2011). 
 
CONCLUSION 
The administration of ESP on ovarectomized rats can increase active osteoblast density and 
dense trabeculae.  
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